Abstract
Th2-skewed immunity in cutaneous T cell lymphoma (CTCL) poses a major clinical challenge and implements a tendency for significant local (skin) and systemic infections with subsequent sepsis. In addition to a global Th2 bias, recent research shows suppressed IL-12-mediated signal transduction in T cells from patients with Sèzary syndrome, associated with the absence of IL-12 receptor beta, but also with decreased IL-12 levels in advanced stage of the disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
